Peter F. Belamarich, M.D.

Medicine & Life Sciences

1. Pediatrics 100%
2. Child 71%
3. Hydroxymethylglutaryl-CoA Reductase Inhibitors 70%
4. Infant Formula 58%
5. Pediatricians 43%
6. Sitosterolemia 43%
7. cholesterol reductase 42%
8. gamma-sitosterol 37%
9. Retropharyngeal Abscess 36%
10. Hyperlipoproteinemia Type II 36%
11. Peritonsillar Abscess 35%
12. Cholesterol 35%
13. Aminocaproic Acid 33%
14. Adverse Childhood Experiences 33%
15. Cholestyramine Resin 32%
16. Insurance Claim Review 32%
17. Drowning 31%
18. Social Determinants of Health 30%
19. United States Food and Drug Administration 30%
20. Aprotinin 29%
21. Tonsillitis 29%
22. Congenital Diaphragmatic Hernias 29%
23. Cholelithiasis 28%
24. Knowledge Bases 27%
25. Homozygote 25%
26. Marketing 24%
27. Hypercholesterolemia 24%
28. Poverty 24%
29. Chronic Hepatitis B 24%
30. Safety 22%
31. Quality Improvement 22%
32. Esophagus 21%
33. Hypertrophy 20%
34. Thoracic Surgery 20%
35. Gastroesophageal Reflux 19%
36. Communicable Diseases 19%
37. Obesity 19%
38. Nutrients 19%
39. Appointments and Schedules 18%
40. Colic 18%
41. Sterols 18%
42. Asthma 17%
43. Inpatients 17%
44. Direction compound 16%
45. Lipids 16%
46. Pharyngitis 16%
47. Diet 15%
48. Infections 15%
49. Coenzyme A 14%
50. Streptococcus 14%